Number of shares outstanding for United Therapeutics (UTHR)

Number of shares outstanding as of October 2026 : 42,600,000

According to United Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 42,600,000. At the end of 2026 the company had 42,600,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for United Therapeutics from 2009 to 2026

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2026	42.6 M	-1.62%
2025	43.3 M	-3.13%
2024	44.7 M	-4.89%
2023	47 M	2.62%
2022	45.8 M	1.55%
2021	45.1 M	1.35%
2020	44.5 M	1.37%
2019	43.9 M	0.69%
2018	43.6 M	0.93%
2017	43.2 M	2.37%
2016	42.2 M	-7.63%
2015	45.68 M	-3.68%
2014	47.43 M	-5.67%
2013	50.28 M	-2.39%
2012	51.51 M	-11.67%
2011	58.32 M	3.16%
2010	56.53 M	5.76%
2009	53.45 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Pfizer PFE	5,699,000,000	13,277.93%	🇺🇸 USA
Eli Lilly LLY	891,500,000	1,992.72%	🇺🇸 USA
Baxter BAX	517,000,000	1,113.62%	🇺🇸 USA
Gilead Sciences GILD	1,243,000,000	2,817.84%	🇺🇸 USA
Cardinal Health CAH	234,000,000	449.30%	🇺🇸 USA
GSK plc GSK	2,007,000,000	4,611.27%	🇬🇧 UK
Cytokinetics CYTK	132,086,000	210.06%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	1,165,000,000	2,634.74%	🇮🇱 Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions